Biomarin Pharmaceutical (BMRN) Change in Intangibles (2017 - 2025)
Historic Change in Intangibles for Biomarin Pharmaceutical (BMRN) over the last 9 years, with Q3 2025 value amounting to $5.3 million.
- Biomarin Pharmaceutical's Change in Intangibles rose 9546.63% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year decrease of 6664.91%. This contributed to the annual value of $12.0 million for FY2024, which is 983.52% up from last year.
- According to the latest figures from Q3 2025, Biomarin Pharmaceutical's Change in Intangibles is $5.3 million, which was up 9546.63% from $266000.0 recorded in Q2 2025.
- Biomarin Pharmaceutical's Change in Intangibles' 5-year high stood at $15.6 million during Q4 2021, with a 5-year trough of $266000.0 in Q2 2025.
- Over the past 5 years, Biomarin Pharmaceutical's median Change in Intangibles value was $1.8 million (recorded in 2022), while the average stood at $3.5 million.
- Per our database at Business Quant, Biomarin Pharmaceutical's Change in Intangibles plummeted by 9570.45% in 2022 and then skyrocketed by 248064.52% in 2024.
- Over the past 5 years, Biomarin Pharmaceutical's Change in Intangibles (Quarter) stood at $15.6 million in 2021, then tumbled by 95.7% to $671000.0 in 2022, then soared by 1059.31% to $7.8 million in 2023, then crashed by 90.11% to $769000.0 in 2024, then soared by 589.6% to $5.3 million in 2025.
- Its Change in Intangibles stands at $5.3 million for Q3 2025, versus $266000.0 for Q2 2025 and $769000.0 for Q4 2024.